STOCK TITAN

Chad M. Robins plans Rule 144 sale of ADPT (NASD: ADPT) stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Chad M. Robins filed a Rule 144 notice to sell 124,998 shares of common stock, with an aggregate market value of $2,298,713.22, through Goldman Sachs & Co. LLC on or about 02/02/2026 on the NASD exchange.

The shares include stock acquired as performance-based compensation on 03/04/2022 (119,419 shares) and earlier founder’s shares from 09/01/2009 (5,579 shares). The issuer had 152,665,188 shares outstanding. Robins has already completed multiple common stock sales in recent months between 11/10/2025 and 01/05/2026.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ADPT Rule 144 filing by Chad M. Robins disclose?

The filing discloses that Chad M. Robins plans to sell 124,998 shares of ADPT common stock under Rule 144. It provides details about the planned broker, market value, prior sales, acquisition dates, and how the shares were originally obtained.

How many ADPT shares is Chad M. Robins planning to sell under Rule 144?

Chad M. Robins plans to sell 124,998 shares of ADPT common stock. The filing lists an aggregate market value of $2,298,713.22 for this block, to be sold through Goldman Sachs & Co. LLC on or about February 2, 2026.

How were the ADPT shares in Chad M. Robins’ Rule 144 filing acquired?

Most of the shares, 119,419, were acquired on March 4, 2022 as performance-based compensation from the issuer. An additional 5,579 shares are listed as founder’s shares acquired on September 1, 2009, also from the issuer.

What recent ADPT stock sales by Chad M. Robins are listed in the filing?

The filing lists multiple ADPT common stock sales between November 10, 2025 and January 5, 2026. Individual transactions range from about 1,237 to 41,670 shares, with gross proceeds per trade generally in the several-hundred-thousand-dollar range.

How many ADPT shares were outstanding when the Rule 144 sale was planned?

The filing states that 152,665,188 shares of ADPT common stock were outstanding. This figure provides baseline context for the planned 124,998-share Rule 144 sale proposed by Chad M. Robins through Goldman Sachs & Co. LLC.

Which broker and exchange are named for the planned sale of ADPT shares?

Goldman Sachs & Co. LLC, located at 200 West Street, New York, NY 10282, is listed as the broker for the planned 124,998-share sale. The securities are expected to trade on the NASD market according to the filing.
Adaptive Biotechnologies

NASDAQ:ADPT

ADPT Rankings

ADPT Latest News

ADPT Latest SEC Filings

ADPT Stock Data

2.64B
149.19M
2.34%
97.89%
5.54%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SEATTLE